SEATTLE--(BUSINESS WIRE)--Dendreon Corporation (NASDAQ:DNDN) today reported results for the third quarter ended September 30, 2011. Net revenue for the quarter ended September 30, 2011 was $64.3 million compared to $20.2 million for the quarter ended September 30, 2010. This included a $4.3 million reserve for rebates and chargebacks associated with either Medicaid patients or mandated federal programs under the public health services act. Gross product revenue for the quarter ended September 30, 2011, excluding the impact of rebates and chargebacks, was $65.8 million compared to $20.2 million for the quarter ended September 30, 2010. Net revenue for the nine months ended September 30, 2011 was $139.5 million compared to $23.1 million for the nine months ended September 30, 2010. Gross product revenue for the nine months ended September 30, 2011, excluding the impact of $9.0 million associated with rebates and chargebacks, was $145.6 million. This $9.0 million includes $2.4 million which is attributable to sales made in the first and second quarters of 2011; aggregate chargebacks and rebates for the first three quarters of 2011 are $1.4 million in the first quarter, $3.3 million in the second quarter and $4.3 million in the third quarter.
